QualityStocksNewsBreaks Archives - Page 763 of 1422

WednesdayFeb 17, 2021 11:30 am

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Enters Share Purchase Agreement with Lords of Grasstown

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”) today announced its entry into a share purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd., a company existing under the laws of British Columbia (“Grasstown”) pursuant to which the company will acquire all the issued and outstanding shares of Grasstown (the “transaction ”). According to the update, Grasstown is a well-established cannabis motorcycle lifestyle brand with a tremendous following and acumen that spawned from the vision of Tyler Hazelwood, founder and director of Lords of Gastown. “PacRoots is thrilled to partner with such an incredible brand and story driven by…

WednesdayFeb 17, 2021 11:04 am

QualityStocksNewsBreaks – Amesite Inc. (NASDAQ: AMST) Finds Sweet Spot Amid Surging Demand for Online Learning

Amesite (NASDAQ: AMST) today announced its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. The publication, titled “Essential E-Learning Ecosystems Move to the Head of the Class,” discusses the trend toward digital online learning in education and business. Amesite is positioned as demand surges for customized and scalable online learning products in a single, easy-to-use format. The piece reads, “This is the sweet spot for Amesite Inc. (NASDAQ: AMST), an award-winning artificial intelligence (‘AI’) software company that delivers online…

WednesdayFeb 17, 2021 10:47 am

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes on $7.4M Registered Direct Offering, Announces Breakthrough Discoveries

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it had closed on its previously announced registered direct offering. The offering, comprised of 4,222,288 shares of POAI common stock sold at $1.75 per share, totaled $7.4 million in gross proceeds for the company, before expenses were deducted. The shares were priced at-the-market under Nasdaq rules. The announcement also noted that the company issued a concurrent private placement to the same investors; that placement comprised of unregistered warrants up 2,111,144 shares of common stock, priced at $2 per share.…

WednesdayFeb 17, 2021 10:31 am

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Featured in Latest Episode of The Bell2Bell Podcast

CannAssist (OTCQB: CNSC), the parent company of Xceptor Labs and developer of innovative CiBiDinol technology, was featured in an episode of The Bell2Bell Podcast, produced by InvestorBrandNetwork (“IBN”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist, as he discusses the company’s CiBiDinol technology. Palumbo noted that CannAssist’s platform, which was developed as a product of the company’s subsidiary, Xceptor Labs, is capable of improving the performance of CBD and a host of other oil-soluble active ingredients, including non-CBD cannabinoids, terpenes, essential oils…

WednesdayFeb 17, 2021 10:30 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Executes Purchase Agreement to Raise $10.2M

Processa Pharmaceuticals Inc. (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, has executed a securities purchase agreement. The agreement is intended to raise gross proceeds of $10.2 million through the sale of 1,321,132 shares. The shares will be sold at $7.75 per share through a private investment in public equity (“PIPE”) financing. In the announcement, the company reported that the financing attracted both institutional and accredited investors, with the private placement closing expected on or about Feb. 23, 2021. “We believe these additional resources position…

WednesdayFeb 17, 2021 10:07 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) to Supply HempFusion CBD for Potentially Groundbreaking Research at Mount Sinai Medical Hospital

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD as the exclusive brand and the sole supplier in a six-month clinical trial. Dr. David Harnick, a board-certified cardiologist and electrophysiologist and assistant professor in medicine and cardiology at Mount Sinai, is conducting the trial comprised of two studies that is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers. “Studying the potential effects that CBD…

WednesdayFeb 17, 2021 10:01 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Releases Financial Report, Posts Record Q3 2021 Revenue

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, announced that revenue for Q3 2021 reached $10.2 million an increase of $1.7 million year over year and a record for the company. The company also noted that earnings per share for Q3 2021, the period ending Dec. 31, 2020, were up 14.3% compared to the previous year and that the company’s Direct Store Delivery (“DSD”) had reached more than 10,000 customers, with its A888CBD(TM) line seeing its national distribution network increasing with KeHE, UNFI, BettermentRS and broker C.A. Fortune. The…

WednesdayFeb 17, 2021 9:49 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Provides Update on PowerTap 3G Unit

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has announced additional information regarding PowerTap’s third-generation unit, noting that the unit has increased efficiency and reduced operating costs. The technology and unit are being developed by technology from PowerTap Hydrogen Fueling Corp., an investee company of Clean Power. According to the announcement, the system performance of PowerTap’s third-generation onsite hydrogen production module unit is controlled by advanced operating software with data analytics. Data that is collected through the software is sent through the cloud. Subsequently a data analytics application evaluates the information then deploys advance algorithms to…

WednesdayFeb 17, 2021 9:21 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Shareholder Approval of Canopy Growth Plan of Arrangement

Canopy Rivers (TSX: RIV) (OTC: CNPOF) shareholders have voted to approve the company’s previously announced plan of arrangement regarding Canopy Growth Corporation. Shareholder voting resulted in 99.87% of votes cast by Rivers' shareholders cast in favor of the arrangement; that number included an estimated 99.85% of votes cast by Rivers' shareholders other than Canopy Growth. According to the previously announced arrangement, approval was required from at least two-thirds of the votes cast by the holders of subordinated voting shares as well as two-thirds of votes cast by Canopy Growth and a simple majority of votes cast by holders of SVS…

TuesdayFeb 16, 2021 2:02 pm

QualityStocksNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer

Artelo Biosciences (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways including the endocannabinoid system, today announced the appointment of Andrew Yates, Ph.D, as senior vice president and chief scientific officer. Dr. Yates is an experienced senior pharmaceutical executive, having most recently served at AstraZeneca in significant roles across a number of functional areas including development and commercial strategy, medical affairs and business development. Notably, Dr. Yates has been extensively involved in the life-cycle management of key multi-billion-dollar products including CRESTOR(R), FORXIGA(R) and KEYTRUDA(R). “We are extremely pleased to announce the…

Site Search

Company Search

Category: QualityStocksNewsBreaks